|
|
Neural Mechanisms Driving Comorbid Parkinsons and Melanoma |
| 1F31CA268947-01 |
|
NCI |
2022 |
|
|
Chronic Health Conditions in Survivors of Down Syndrome-Associated Leukemia |
| 1R01CA263000-01A1 |
|
NCI |
2022 |
|
|
Preventing Falls and Frailty in Prostate Cancer Survivors: GET FIT Prostate |
| 5R01CA222605-05 |
|
NCI |
2022 |
|
|
Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy |
| 1 R01 CA259188-01 |
|
NCI |
2021 |
|
|
Image-guided combination therapies for radiotherapy-induced neurocognitive impairment in pediatric brain tumor survivors |
| 1 R01 CA262887-01 |
|
NCI |
2021 |
|
|
Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors |
| 1 R21 CA262978-01 |
|
NCI |
2021 |
|
|
Identifying the mechanisms of leukemia progression |
| 1 R35 CA253096-01A1 |
CRISPINO, JOHN D |
NCI |
2021 |
|
|
Developmental Research Program
[Parent Title: Mayo Clinic Hepatobiliary SPORE] |
| 5 P50 CA210964-04 |
|
NCI |
2021 |
|
|
The Role of CHAF1B in Maintaining Malignant Leukemia Stem Cells |
| 5 R00 CA230314-03 |
|
NCI |
2021 |
|
|
Mechanisms of leukemogenesis in Down syndrome |
| 5 R01 CA101774-20 |
CRISPINO, JOHN D |
NCI |
2021 |